2021
DOI: 10.1016/j.jfma.2021.04.014
|View full text |Cite
|
Sign up to set email alerts
|

Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017–2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 34 publications
2
8
0
Order By: Relevance
“…In this study, carbapenem use was a risk factor for K . pneumoniae resistance to carbapenems, in consistent with previous studies [ 44 46 ]. As mentioned above, our study adopted a case-case-control study and compared with other studies using CSKP as the control group; our results truly reflected the effect of carbapenem use.…”
Section: Discussionsupporting
confidence: 93%
“…In this study, carbapenem use was a risk factor for K . pneumoniae resistance to carbapenems, in consistent with previous studies [ 44 46 ]. As mentioned above, our study adopted a case-case-control study and compared with other studies using CSKP as the control group; our results truly reflected the effect of carbapenem use.…”
Section: Discussionsupporting
confidence: 93%
“…Although carbapenems are one of the first choice drugs for the treatment of complex urinary tract infections and severe gram-negative bacterial infections, 36 , 37 many previous studies have suggested that carbapenems exposure history is a risk factor for CRKP infection. 38 , 39 Our multivariate analysis supported these hypotheses. Our multivariate analysis also found that exposure to the BLBLIs was an independent risk factor for hospital-acquired CRKP BSI, a correlation rarely mentioned in previous studies.…”
Section: Discussionsupporting
confidence: 72%
“…The mortality of CRKP infection is higher, with a value of 27.3% reported in a previous study [22]. Compared with carbapenem-susceptible K. pneumoniae, CRKP in BSI is associated with significantly worse 2-week survival [23]. Difficult-to-treat Gram-negative BSI and more severe lower respiration tract infection are associated with increased inhospital mortality within one month and appropriate empirical antibiotics related to lower mortality [24].…”
Section: Discussionmentioning
confidence: 94%